Insight into the molecular basis of Schistosoma haematobium-induced bladder cancer through urine proteomics (Q35948339)

11 August 2017

title

Insight into the molecular basis of Schistosoma haematobium-induced bladder cancer through urine proteomics (English)

1 reference

11 August 2017

main subject

Schistosoma haematobium

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26951512%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Paul J. Brindley

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26951512%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Francisco Amado

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26951512%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Rita Ferreira

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26951512%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Rui Vitorino

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26951512%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

author name string

Maria Cláudia Cunha

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26951512%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Júlio Henrique Santos

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26951512%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

José M Correia da Costa

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26951512%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Carlos Lopes

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26951512%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Lúcio Lara Santos

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26951512%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

language of work or name

1 reference

7 March 2016

1 reference

11 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26951512%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26951512%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26951512%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

11279-11287

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26951512%20AND%20SRC:MED&resulttype=core&format=json

Global burden of cancers attributable to infections in 2008: a review and synthetic analysis

1 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4997-Y

Infectious agents and cancer: criteria for a causal relation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4997-Y

Why does infection with some helminths cause cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4997-Y

Hypermethylation of Genes Detected in Urine from Ghanaian Adults with Bladder Pathology Associated with Schistosoma haematobium Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4997-Y

Targeting molecular signaling pathways of Schistosoma haemotobium infection in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4997-Y

Schistosome and liver fluke derived catechol-estrogens and helminth associated cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4997-Y

Estrogen-like metabolites and DNA-adducts in urogenital schistosomiasis-associated bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4997-Y

Comparative proteomic analyses of urine from rat urothelial carcinoma chemically induced by exposure to N-butyl-N-(4-hydroxybutyl)-nitrosamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4997-Y

Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4997-Y

Epistemology of the origin of cancer: a new paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4997-Y

Killing of schistosomes by elastase and hydrogen peroxide: implications for leukocyte-mediated schistosome killing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4997-Y

Robo4 is a vascular-specific receptor that inhibits endothelial migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4997-Y

Schistosoma mansoni infection causes oxidative stress and alters receptor for advanced glycation endproduct (RAGE) and tau levels in multiple organs in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4997-Y

Inhibition of myeloperoxidase- and neutrophil-mediated oxidant production by tetraethyl and tetramethyl nitroxides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4997-Y

Biochemical and pathological studies on peroxidases -an updated review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4997-Y

Association of myeloperoxidase with ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4997-Y

Silencing of Lactotransferrin expression by methylation in prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4997-Y

Defense peptides secreted by helminth pathogens: antimicrobial and/or immunomodulator molecules?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4997-Y

Antimicrobial peptides: an alternative for innovative medicines?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4997-Y

Cathelicidin-like helminth defence molecules (HDMs): absence of cytotoxic, anti-microbial and anti-protozoan activities imply a specific adaptation to immune modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4997-Y

Antibiotic proteins of human polymorphonuclear leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4997-Y

Elevated urine levels of heparin-binding protein in children with urinary tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4997-Y

A Decade of FGF Receptor Research in Bladder Cancer: Past, Present, and Future Challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4997-Y

Epidermal growth factor induces bladder cancer cell proliferation through activation of the androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4997-Y

Overexpression of LAMP3/TSC403/DC-LAMP promotes metastasis in uterine cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4997-Y

E-cadherin gene promoter hypermethylation may contribute to the risk of bladder cancer among Asian populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4997-Y

The role of peroxiredoxin II in chemoresistance of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4997-Y

S100A8 and S100A9 in inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4997-Y

Omega-1, a glycoprotein secreted by Schistosoma mansoni eggs, drives Th2 responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4997-Y

Changing patterns (age, incidence, and pathologic types) of schistosoma-associated bladder cancer in Egypt in the past decade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4997-Y

Mutations in the p53 gene in schistosomal bladder cancer: a study of 92 tumours from Egyptian patients and a comparison between mutational spectra from schistosomal and non-schistosomal urothelial tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4997-Y

P53 and cancer-associated sialylated glycans are surrogate markers of cancerization of the bladder associated with Schistosoma haematobium infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4997-Y

Pursuing type 1 diabetes mellitus and related complications through urinary proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4997-Y

Complement Factor H as a Marker for Detection of Bladder Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4997-Y

Dendritic cell-intrinsic expression of NF-kappa B1 is required to promote optimal Th2 cell differentiation

21 January 2018

1 reference

12 December 2020

Hyaluronate levels and markers of oxidative stress in the serum of Sudanese subjects at risk of infection with Schistosoma mansoni

1 reference

12 December 2020

1 reference

12 December 2020

Discovery of novel bladder cancer biomarkers by comparative urine proteomics using iTRAQ technology

1 reference

12 December 2020

Participation of mammalian defensins and cathelicidins in anti-microbial immunity: receptors and activities of human defensins and cathelicidin (LL-37).

1 reference

12 December 2020

Comparison of findings using ultrasonography and cystoscopy in urogenital schistosomiasis in a public health centre in rural Angola.

1 reference

12 December 2020

Relationship between schistosomiasis and bladder cancer

1 reference

12 December 2020

The over expression of cathelicidin peptide LL37 in head and neck squamous cell carcinoma: the peptide marker for the prognosis of cancer

1 reference

12 December 2020